A Novel Comprehensive Clinical Stratification Model to Refine Prognosis of Glioblastoma Patients Undergoing Surgical Resection

Despite recent discoveries in genetics and molecular fields, glioblastoma (GBM) prognosis still remains unfavorable with less than 10% of patients alive 5 years after diagnosis. Numerous studies have focused on the research of biological biomarkers to stratify GBM patients. We addressed this issue i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ius, Tamara, Pignotti, Fabrizio, Della Pepa, Giuseppe Maria, La Rocca, Giuseppe, Somma, Teresa, Isola, Miriam, Battistella, Claudio, Gaudino, Simona, Polano, Maurizio, Dal Bo, Michele, Bagatto, Daniele, Pegolo, Enrico, Chiesa, Silvia, Arcicasa, Mauro, Olivi, Alessandro, Skrap, Miran, Sabatino, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072471/
https://www.ncbi.nlm.nih.gov/pubmed/32046132
http://dx.doi.org/10.3390/cancers12020386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072471/
https://www.ncbi.nlm.nih.gov/pubmed/32046132
http://dx.doi.org/10.3390/cancers12020386

Ejemplares similares